Klépierre's shares show signs of a reversal to the downside. The technical chart pattern has deteriorated and suggests a continuation of the decline. Investors should open a short trade and target the € 32.
For a short-term investment strategy, the company has poor fundamentals.
The group's activity appears highly profitable thanks to its outperforming net margins.
Historically, the company has been releasing figures that are above expectations.
Its low valuation, with P/E ratio at 10.26 and 10.91 for the ongoing fiscal year and 2018 respectively, makes the stock pretty attractive with regard to earnings multiples.
This company will be of major interest to investors in search of a high dividend stock.
For the past year, analysts covering the stock have been revising their EPS expectations upwards in a significant manner.
Analysts covering this company mostly recommend stock overweighting or purchase.
The average target price set by analysts covering the stock is above current prices and offers a tremendous appreciation potential.
As estimated by analysts, this group is among those businesses with the lowest growth prospects.
One of the major weak points of the company is its financial situation.
Prospects from analysts covering the stock are not consistent. Such dispersed sales estimates confirm the poor visibility into the group's activity.
Based on current prices, the company has particularly high valuation levels.
Recevoir les alertes
The information, charts, data, views, or comments provided by SURPERFORMANCE SAS are intended for investors who have the necessary knowledge and experience to understand and appreciate the information contained within. These items are disseminated for personal reference only. They do not constitute an offer or solicitation to buy or sell financial products or services, nor an investment advice.
The use of the information disseminated takes place under the investor's sole responsibility, without recourse against SURPERFORMANCE SAS. SURPERFORMANCE SAS will not be liable, whether in contract, in tort, under any warranty, for errors, omissions, improper investments, or adverse evolution of markets.